Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

ABU DHABI, 5th April, 2026 (WAM) -- Abu Dhabi Stem Cells Center (ADSCC) has announced a new scientific milestone in regenerative medicine with the development of an advanced technique to generate ...

Northwestern Medicine scientists have discovered new insights into how high gamma activity—an informative, widely studied ...

In the field of neuro-oncology, the dual topics of cellular metabolism and the tumor microenvironment (TME) have gained ...

Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...

While each method has its pros and cons, a joint study found that LC-MS provides a clearer, more comprehensive picture of the ...

Lymph nodes are key control centers in the immune system and play an important role in defending the body against infections ...

Scientists have identified a previously unknown genetic disease that causes premature aging and cognitive impairment. The ...